L Borradori Selected Research

L Borradori Research Topics

Disease

15	Bullous Pemphigoid (Pemphigoid) 10/2021 - 05/2000
10	Pemphigus (Pemphigus Vulgaris) 04/2022 - 02/2001
5	Blister (Bulla) 07/2017 - 05/2000
4	Neoplasms (Cancer) 10/2021 - 01/2011
3	Infections 03/2019 - 01/2001
3	Oral Lichen Planus 05/2017 - 06/2015
3	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 01/2004 - 08/2000
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2019 - 04/2019
2	Autoimmune Diseases (Autoimmune Disease) 08/2018 - 05/2017
2	Necrosis 05/2017 - 03/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2016 - 06/2005
2	Pain (Aches) 06/2015 - 03/2015
2	Panniculitis 01/2014 - 09/2005
2	Immunoglobulin Light-chain Amyloidosis 01/2014 - 01/2003
2	Cicatrix (Scar) 11/2011 - 01/2004
2	Stomatitis 04/2003 - 03/2001
1	Skin Neoplasms (Skin Cancer) 10/2020
1	Overweight 12/2019
1	Psoriatic Arthritis 12/2019
1	Tuberculosis (Tuberculoses) 12/2019
1	Kidney Diseases (Kidney Disease) 12/2019
1	Cutaneous Lupus Erythematosus 03/2019
1	Alopecia Areata 01/2019
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Virus Diseases (Viral Diseases) 08/2018
1	Keratitis 08/2018
1	Acute Generalized Exanthematous Pustulosis 07/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Port-Wine Stain (Nevus Flammeus) 03/2017
1	Basosquamous Carcinoma 12/2016
1	Angiomatosis 05/2015
1	Foreign-Body Reaction 05/2015
1	Phobic Disorders (Phobia) 03/2015
1	Telangiectasis (Telangiectasia) 03/2015
1	Hypersensitivity (Allergy) 03/2015
1	Allergic Contact Dermatitis 01/2014
1	Amyloidosis 01/2014
1	Bone Resorption 01/2012
1	Atrophy 01/2012

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 01/2018 - 05/2000
7	Immunoglobulin G (IgG)IBA 11/2016 - 05/2000
6	AntigensIBA 01/2018 - 05/2000
4	Rituximab (Mabthera)FDA Link 09/2020 - 02/2001
4	Tacrolimus (Prograf)FDA LinkGeneric 02/2017 - 04/2003
4	AutoantigensIBA 11/2011 - 04/2001
3	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 11/2011
3	AntibodiesIBA 11/2013 - 01/2001
3	Immunoglobulin E (IgE)IBA 11/2011 - 08/2000
2	Immune Checkpoint InhibitorsIBA 02/2020 - 12/2016
2	Adalimumab (Humira)FDA Link 12/2019 - 01/2007
2	Keratins (Keratin)IBA 01/2018 - 05/2000
2	EnzymesIBA 11/2016 - 11/2001
2	ParaffinIBA 11/2016 - 06/2005
2	DesmogleinsIBA 11/2013 - 06/2001
2	Immunoglobulin A (IgA)IBA 06/2001 - 08/2000
1	BNT162 VaccineIBA 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	KalininIBA 10/2021
1	Infliximab (Remicade)FDA Link 12/2019
1	secukinumabIBA 12/2019
1	Etanercept (Enbrel)FDA Link 12/2019
1	Ustekinumab (CNTO 1275)FDA Link 12/2019
1	fumaric acid (sodium fumarate)IBA 12/2019
1	Methotrexate (Mexate)FDA LinkGeneric 12/2019
1	RetinoidsIBA 12/2019
1	Antiviral Agents (Antivirals)IBA 03/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Biological ProductsIBA 08/2018
1	IpilimumabIBA 07/2018
1	NivolumabIBA 07/2018
1	DesminIBA 01/2018
1	Desmoplakins (Desmoplakin)IBA 01/2018
1	CytokinesIBA 05/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2017
1	Fas Ligand Protein (Fas Ligand)IBA 05/2017
1	Interferon-gamma (Interferon, gamma)IBA 05/2017
1	InterferonsIBA 05/2017
1	InterleukinsIBA 05/2017
1	Caspase 3 (Caspase-3)IBA 05/2017
1	Interleukin-9 (Interleukin 9)IBA 05/2017
1	ImmunosorbentsIBA 11/2016
1	Formaldehyde (Formol)FDA Link 11/2016
1	Prostaglandins AIBA 07/2016
1	Polidocanol (Laureth)FDA Link 03/2015
1	AluminumIBA 03/2015
1	Sclerosing Solutions (Sclerosing Agents)IBA 03/2015
1	YttriumIBA 03/2015
1	NeodymiumIBA 03/2015
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2014
1	PlakinsIBA 11/2013
1	Proteins (Proteins, Gene)FDA Link 11/2013

Therapy/Procedure

11	Therapeutics 12/2019 - 01/2001
2	Lasers (Laser) 05/2017 - 03/2017
1	Secondary Prevention 10/2020
1	Investigational Therapies (Experimental Therapy) 10/2020
1	Biological Therapy 12/2019
1	Knee Replacement Arthroplasty (Total Knee Replacement) 05/2015
1	Sclerotherapy 03/2015
1	Solid-State Lasers 03/2015
1	Tattooing 01/2014